Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Our Products
MouseAtlas
iPSC Cell Lines
Knockout Cell Lines
Tumor Cell Lines
Adeno-associated Virus (AAV) Standard Capsid
Featured Catalog
Humanized Mouse Models
HUGO-GT™
HUGO-Ab™
Humanized Target Gene Models
Humanized Immune System Mouse Models
Tool Mice
Cre Mouse Lines
Disease Models
Autoimmune Disease Models
Ophthalmic Disease Models
Immunodeficient Mouse Models
Metabolic Disease Models
Neurological Disease Models
Oncology & Immuno-oncology Models
Services
Model Generation Techniques
Turboknockoutᵀᴹ Gene Targeting
Cre-ESCs Gene Editing
Targeted Gene Editing
Genetically Engineered Animals
Knockin Mice
Knockin Rats
Knockout Mice
Knockout Rats
Transgenic Mice
Transgenic Rats
Transgenic Model Generation
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Adenovirus Packaging
Lentivirus Packaging
Custom Cell Line Services
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Overexpression Cell Lines
Point Mutation Cell Lines
Breeding & Supporting Services
BAC Modification
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
Drug Discovery and Development
Antibody Discovery Platform
HUGO-Ab™
HUGO-Mab™
HUGO-Light™
HUGO-Nano™
HUGO-Ab-eKO™
Therapeutic Area
Neurology
Alzheimer's Disease (AD)
Parkinson's Disease (PD)
Huntington's Disease (HD)
Blood Brain Barrier (BBB)
Neuropathic Pain
Metabolic & Cardiovascular
Obesity
Ophthalmology
Glaucoma
Age-Related Macular Degeneration (AMD)
Oncology
PBMC Humanized Mouse Model
Human Immune System (HIS) Mouse Model
Immunology & Inflammation
Asthma
Innovative Drug R&D
Therapeutic Antibody Drugs
Monoclonal Antibodies (mAb)
Bispecific Antibodies (BsAb)
ADC/AOC
AI-Powered AAV Discovery
Cell Immunotherapy
Gene Therapy
Oligonucleotide Therapy
Fully Human Antibody Library
Neurology Antibodies
Metabolic & Cardiovascular Antibodies
Ophthalmology Antibodies
Oncology Antibodies
Immunology & Inflammation Antibodies
Resources
News
Blogs & Insight
Promotion
Events & Webinars
Databases
AbSeek
Rare Disease Data Center
Cell iGeneEditor™ System
Citations
Resource Vault
OriCell
About Us
Animal Health & Welfare
Corporate Overview
Facility Overview
Our Team
Our Partners
Careers
Health Reports
Contact Us
Login
Tired of Endless Troubleshooting and Project Delays?

Building a stable, verified cell line in-house is time-consuming, resource-intensive, and often fraught with unexpected failures. Don't let your core research wait. Our expert team can deliver fully validated cell lines, freeing you to focus on your next breakthrough.

Our Fall 2025 Kickstart Offers

We're making it easier than ever to outsource your cell line engineering. Choose the offer that best fits your project needs.

Flash Sale on Popular Cell Lines
Offer valid through November 30, 2025.
Service Type Flash Sale Price Eligible Cell Lines Turnaround Time
Knockout (KO) $2,100 HEK293, THP1, A549, Hela, MC38, C2C12 From 6 Weeks
Point Mutation $4,050
Knock-in (KI <3kb) $5,100
Overexpress Cell Line $2,100
Request Flash Sale Price
New Client Special: 50% Off Your First Custom Project
Offer valid for new clients through December 31, 2025.
Service Type 50% Off Price Details Turnaround Time
Knockout (KO) $2,950 Applicable to over 80% of common cell lines (e.g., Jurkat, HepG2, PC3). From 6 Weeks
Point Mutation $4,650
Knock-in (KI <3kb) $5,500
Interference Cell Line $2,800
Claim My 50% Discount
Quality and Expertise You Can Count On

Your project's success is our priority. We don't compromise on quality, even during a promotion.

State-of-the-art Gene Editing Expertise
Over 2,000 projects successfully delivered. Alpha donor system empowers high-efficiency knock-in
Advanced ipSC Technology
One-stop solution from iPSC reprogramming, gene editing, to differentiation
Universal Stable Cell Engineering Technology
Universal stable cellines to meet any customer demand for drug discovery and development
Best Value
A professional scientific and project management team dedicated to supporting customers
From Concept to Cells in 4 Simple Steps
1
Submit Your Project
Fill out our quick form with your gene and cell line of interest.
2
Strategy Design
Our experts design the optimal gRNA and donor strategy, which you review and approve.
3
Generation & Validation
We perform the editing, single-cell cloning, and all the necessary QC.
4
Delivery
You receive your project-ready materials, enabling you to start your experiments immediately.
What You'll Receive (Standard Deliverables)
Item Description Quantity
Engineered Cells Your custom-edited clonal cell line (homozygous or heterozygous as per project). 2 vials (1x10⁶ cells/vial)
Parental WT Cells The original, unmodified wild-type cells for use as a control. 2 vials (1x10⁶ cells/vial)
QC Report Comprehensive documentation including PCR and Sanger sequencing validation, plus mycoplasma & sterility test results. 1 Full Report
Ready to Advance Your Research?

Don't miss this opportunity to get expert-built, fully-validated cell lines at a fraction of the cost. Secure your promotional pricing today.

Contact Form Below
Flash Sale KO Flash Sale PM 50% Off Custom Project, etc.
Gene Cell Line, etc.
Email Newsletter LinkedIn Google/Search Colleague Referral Conference/Event Other
Within 1 month 1-3 months 3-6 months >6 months / Planning stage
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0336
Email:
inquiry@cyagen.com
Services
HUGO-GT™HUGO-Ab™iPSC Cell LinesAdeno-associated Virus (AAV) Standard Capsid
Drug R&D
NeurologyMetabolicOphthalmologyOncology
About Us
Animal Health & WelfareCorporate OverviewOur TeamHealth Reports
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Global Antibody Drug Industry Development BlueBook (Frost & Sullivan)
Key Insights
The industry is undergoing a rapid transformation driven by next-generation modalities, globalized markets, and upstream technological innovations.
  • Market Structural Shift: Monoclonal antibodies drive steady growth, but ADCs and bispecifics are rapidly accelerating, reshaping the market with higher-value innovations.
  • Chinese Market Globalization: China is actively expanding globally, evidenced by a surge in high-value cross-border license-out deals.
  • Technology-Driven Efficiency: Advanced discovery engines—exemplified by Cyagen's HUGO-Ab platform and AI algorithms—are streamlining candidate screening, optimizing molecular design, and localizing the upstream supply chain.
  • Oncology-Focused Innovation: R&D pipelines remain heavily concentrated on high-incidence malignancies like non-small cell lung cancer, utilizing complex modalities to combat clinical resistance.
Now Available for Download
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest
Main Area of Research